BridgeMD
New treatment option for Stroke
Official title Brain Stimulation Combined With Watching Hand Movements to Improve Hand Recovery in Chronic Stroke
ClinicalTrials.gov ID: NCT07400939
What this study is testing
- What it's testing
- This study investigates the neurophysiological mechanisms underlying the combined use of transcranial direct current stimulation (tDCS) and action observation therapy (AOT) for hand motor recovery in individuals with stroke. Background: While both tDCS and AOT have shown promise individually for stroke rehabilitation, the neural mechanisms of their combined effects remain unclear.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 59
You may be able to join if
- Adults aged 18 to 59 years
- Single episode of unilateral stroke and weakness in hand muscles 6 to 24 months post-stroke
- No excessive spasticity of the upper limb, defined as grade two or less on Modified Ashworth Scale
You likely can't join if
- Patients diagnosed with posterior circulation infarction
- Unable to follow commands due to poor cognitive function
- Unilateral neglect
- Homonymous hemianopia
- Other existing neurological disorders that lead to poor hand function
- Grade four or five hand muscle strength.
The study team makes the final eligibility decision.
Where it's taking place
- Kota Kinabalu, Sabah, Malaysia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kota Kinabalu, Sabah, Malaysia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.